An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
Clinical trial NCT00355901 · TERMINATED
Trial details
- NCT number
- NCT00355901
- Sponsor
- PDL BioPharma, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2006-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.